A Quick Look at Today's Ratings for LifeMD(LFMD.US), With a Forecast Between $8 to $15
LifeMD's Earnings Call: Positive Growth and Strategic Expansion
LifeMD Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results and Raised Its FY25 Sales Guidance.
Express News | LifeMD Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results and Raised Its FY25 Sales Guidance
H.C. Wainwright Maintains LifeMD(LFMD.US) With Buy Rating, Maintains Target Price $14
Express News | LifeMD Inc : Mizuho Raises Target Price to $8 From $7
LifeMD, Inc. (LFMD) Q1 2025 Earnings Call Transcript Summary
LifeMD Reports Q1 EPS 1c, Consensus 14c
LifeMD Raises FY25 Revenue View to $268M-$275M From $265M-$275M
10-Q: Q1 2025 Earnings Report
Express News | LifeMD Inc: Q1 EPS $0.01
8-K: LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Guidance
Express News | LifeMD Q1 Gross Margin 87%
Express News | LifeMD Q1 Revenue USD 65.7 Million Vs. IBES Estimate USD 62.6 Million
Express News | LifeMD Outlook FY Revenue USD 268-275 Million
Express News | LifeMD Outlook FY Adjusted Ebitda USD 31-33 Million
Express News | LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Guidance
LifeMD Options Imply 12.4% Move in Share Price Post-earnings
Here Are the Major Earnings After the Close Today
Earnings Scheduled For May 6, 2025